Page last updated: 2024-11-07

beauvericin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Beauvericin is a cyclic hexadepsipeptide mycotoxin produced by various fungi, particularly Fusarium and Beauveria species. It exhibits a wide range of biological activities, including immunosuppressive, cytotoxic, and antibiotic effects. Its synthesis involves the condensation of three amino acids (D-hydroxyisovaleric acid, L-N-methyl-L-valine, and L-phenylalanine) and three non-proteinogenic amino acids (L-N-methyl-L-isoleucine, L-N-methyl-L-phenylalanine, and L-N-methyl-L-leucine). Beauvericin's toxicity stems from its ability to disrupt cellular ion transport, particularly potassium, leading to mitochondrial dysfunction and apoptosis. It is studied extensively due to its potential implications in food safety, animal health, and human health. Its presence in contaminated food products poses a risk to consumers, and it can cause various health problems in animals. Research on beauvericin focuses on understanding its biosynthesis, toxicity mechanisms, and developing strategies for its detection and mitigation. It is also investigated for its potential as a biocontrol agent against insects and fungi.'

beauvericin: 18-membered cyclodepsipeptides [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

beauvericin : A trimeric cyclodepsipeptide composed from alternating methylphenylalanyl and hydroxyvaleryl residues. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID3007984
CHEMBL ID249052
CHEBI ID3000
SCHEMBL ID29355
MeSH IDM0045517
PubMed CID105014
CHEMBL ID1977672
SCHEMBL ID6452789
MeSH IDM0045517

Synonyms (30)

Synonym
(3s,6r,9s,12r,15s,18r)-3,9,15-tribenzyl-6,12,18-triisopropyl-4,10,16-trimethyl-1,7,13-trioxa-4,10,16-triazacyclooctadecane-2,5,8,11,14,17-hexone
CHEBI:3000 ,
(3s,6r,9s,12r,15s,18r)-3,9,15-tribenzyl-4,10,16-trimethyl-6,12,18-tri(propan-2-yl)-1,7,13-trioxa-4,10,16-triazacyclooctadecane-2,5,8,11,14,17-hexone
unii-26s048ls2r
26s048ls2r ,
SCHEMBL29355
CHEMBL249052
(3s,6r,9s,12r,15s,18r)-3,9,15-tribenzyl-6,12,18-triisopropyl-4,10,16-trimethyl-1,7,13-trioxa-4,10,16-triazacyclooctadecane-2,5,8,11,14,17-hexaone
NCGC00380798-01
AKOS030622850
DTXSID00891834
CS-W020817
HY-N6739
cyclo(d-.alpha.-hydroxyisovaleryl-n-methyl-l-phenylalanyl-d~ -.alpha.-hydroxyisovaleryl-n-methyl-l-phenylalanyl-d-.alpha.-hydroxyisovaleryl-n-methyl-l-phenylalanyl)
NCI60_038416
beauvericin
26048-05-5
beauvericin, >=97% (hplc)
nsc-708472
1,13-trioxa-4,10,16-triazacyclooctadecane, cyclic peptide deriv.
nsc708472
3,9,15-tribenzyl-4,10,16-trimethyl-6,12,18-tri(propan-2-yl)-1,7,13-trioxa-4,10,16-triazacyclooctadecane-2,5,8,11,14,17-hexone
FT-0602893
SCHEMBL6452789
CHEMBL1977672
beauvericin, vetranal(tm), analytical standard
J-016236
cyclo(d-??-hydroxyisovaleryl-l-n-methyl-phe)3
(3s,6r,9s,12r,15s,18r)-3,9,15-tribenzyl-4,10,16-trimethyl-6,12,18-tripropan-2-yl-1,7,13-trioxa-4,10,16-triazacyclooctadecane-2,5,8,11,14,17-hexone
n-methylcyclo(l-phe-d-hmb-n-methyl-l-phe-d-hmb-n-methyl-l-phe-d-hmb-)

Research Excerpts

Overview

Beauvericin (BEA) is a depsipeptide with antimicrobial, anti-inflammatory, and anti-cancer activities isolated from Beaveria bassiana. It is a world-spread mycotoxin isolated from the traditional Chinese medicine, Bombyx batryticatus.

ExcerptReferenceRelevance
"Beauvericin (BEA) is a secondary metabolite produced by the fungus Beauveria bassiana."( In silico evidence of beauvericin antiviral activity against SARS-CoV-2.
Al Khoury, C; Bashir, Z; Merhi, G; Nemer, G; Nemer, N; Tokajian, S, 2022
)
1.76
"Beauvericin (BEA) is a well-known mycotoxin produced by many fungi, including Beaveria bassiana. "( Study on In Vitro Metabolism and In Vivo Pharmacokinetics of Beauvericin.
Li, Y; Meng, G; Wu, C; Yuan, Y, 2022
)
2.41
"Beauvericin (BEA) is a depsipeptide with antimicrobial, anti-inflammatory, and anti-cancer activities isolated from Beauveria bassiana. "( In vitro anti-cancer effects of beauvericin through inhibition of actin polymerization and Src phosphorylation.
Cho, JY; Kim, HG; Kim, JH; Sung, NY, 2023
)
2.64
"Beauvericin is a world-spread mycotoxin isolated from the traditional Chinese medicine, Bombyx batryticatus (BB), which has been widely used to treat various neoplastic diseases. "( Beauvericin exerts an anti-tumor effect on hepatocellular carcinoma by inducing PI3K/AKT-mediated apoptosis.
Jin, M; Li, J; Li, M; Liu, W; Qiao, Y; Song, Y; Wang, G; Yang, D; Yin, J; Zhao, Y, 2023
)
3.8
"Beauvericin (BEA) is an emerging mycotoxin produced by some species of Fusarium genera that widely contaminates food and feed. "( Beauvericin Immunotoxicity Prevention by
Cimbalo, A; Di Matteo, G; Mannina, L; Manyes, L, 2023
)
3.8
"Beauvericin (BEA) is a mycotoxin produced by Beauveria bassiana and Fusarium species recently reported as toxic on porcine oocyte maturation and embryo development. "( The mycotoxin beauvericin induces oocyte mitochondrial dysfunction and affects embryo development in the juvenile sheep.
Ciani, E; Dell'Aquila, ME; Lacalandra, GM; Martino, NA; Marzano, G; Mastrorocco, A; Minervini, F; Roelen, BAJ, 2019
)
2.32
"Beauvericin (BEA) is a natural bioactive compound, with a dual nature. "( Beauvericin: The beauty and the beast.
Anadón, A; Bertero, A; Caloni, F; Fossati, P, 2020
)
3.44
"Beauvericin (BEA) is a non-legislated emergent mycotoxin while Ochratoxin A (OTA) has been widely studied and legislated."( Beauvericin and ochratoxin A mycotoxins individually and combined in HepG2 cells alter lipid peroxidation, levels of reactive oxygen species and glutathione.
Ben-Mahmoud, M; Carbone, S; Juan-García, A; Mañes, J; Sagratini, G, 2020
)
2.72
"Beauvericin (BEA) is a member of the enniatin family of mycotoxins which has received increasing interest because of frequent occurrence in food and feed. "( Beauvericin alters the expression of genes coding for key proteins of the mitochondrial chain in ovine cumulus-oocyte complexes.
Ciani, E; Dell'Aquila, ME; Mastrorocco, A; Minervini, F; Nicassio, L; Roelen, BAJ, 2021
)
3.51
"Beauvericin is an ubiquitous mycotoxin with relevant occurrence in food and feed. "( The mycotoxin beauvericin impairs development, fertility and life span in the nematode Caenorhabditis elegans accompanied by increased germ cell apoptosis and lipofuscin accumulation.
Baier, S; Büchter, C; Freyer, M; Honnen, S; Koch, K; Saier, C; Wätjen, W, 2020
)
2.36
"Beauvericin (BEA) is a mycotoxin present in cereals that produces cytotoxicity, intracellular reactive oxygen species and lipid peroxidation."( Antioxidant capacity of trans-resveratrol dietary supplements alone or combined with the mycotoxin beauvericin.
Brandolini, V; Font, G; Maietti, A; Mallebrera, B; Ruiz, MJ; Tedeschi, P, 2017
)
1.39
"Beauvericin (BEA) is a mycotoxin produced by many species of fungus Fusarium and by Beauveria bassiana; BEA is a natural contaminant of cereals and cereals based products and possesses a wide variety of biological properties. "( In vitro mechanisms of Beauvericin toxicity: A review.
Font, G; Mallebrera, B; Prosperini, A; Ruiz, MJ, 2018
)
2.23
"Beauvericin is a mycotoxin which has insecticidal, anti-microbial, anti-viral and anti-cancer activities. "( Beauvericin synthetase contains a calmodulin binding motif in the entomopathogenic fungus Beauveria bassiana.
Kim, J; Sung, GH, 2018
)
3.37
"Beauvericin (BEA) is a cyclic hexadepsipeptide, which derives from Cordyceps cicadae. "( Beauvericin, A Fusarium Mycotoxin: Anticancer Activity, Mechanisms, and Human Exposure Risk Assessment.
Kuca, K; Patocka, J; Wu, Q, 2019
)
3.4
"Beauvericin (BEA) is a bioactive compound produced by the secondary metabolism of several Fusarium strains with a strong antibacterial, antifungal, and insecticidal activities. "( A chemical approach for the reduction of beauvericin in a solution model and in food systems.
Luciano, FB; Mañes, J; Manyes, L; Meca, G, 2014
)
2.11
"Beauvericin is a world-spread mycotoxin with a high toxicity in mammalian cells. "( The mycotoxin beauvericin induces apoptotic cell death in H4IIE hepatoma cells accompanied by an inhibition of NF-κB-activity and modulation of MAP-kinases.
Chovolou, Y; Debbab, A; Hohlfeld, A; Proksch, P; Wätjen, W, 2014
)
2.21
"Beauvericin (BEA) is a secondary metabolite produced by many species of fungus Fusarium. "( Mechanisms of beauvericin toxicity and antioxidant cellular defense.
Font, G; Juan-Garcia, A; Mallebrera, B; Ruiz, MJ, 2016
)
2.24
"Beauvericin (BEA) is a cyclic hexadepsipeptide that derives from Codyceps cicadae. "( Beauvericin-induced cell apoptosis through the mitogen-activated protein kinase pathway in human nonsmall cell lung cancer A549 cells.
Chen, BF; Jow, GM; Lin, HI; Lu, CL, 2016
)
3.32
"Beauvericin is a secondary metabolite natural product from microorganisms and has been shown to have a new potential antifungal activity. "( An inhibition study of beauvericin on human and rat cytochrome P450 enzymes and its pharmacokinetics in rats.
Dai, R; Mei, L; Zhang, L, 2009
)
2.11
"Beauvericin is a naturally occurring cyclohexadepsipeptide originally described from Beauveria bassiana but also reported from several Fusarium species as well as members of the genus Isaria. "( A beauvericin hot spot in the genus Isaria.
Berkaew, P; Hywel-Jones, NL; Isaka, M; Luangsa-Ard, JJ; Ridkaew, R, 2009
)
2.52
"Beauvericin (BEA) is a cyclic hexadepsipeptide mycotoxin with notable phytotoxic and insecticidal activities. "( Modeling of Fusarium redolens Dzf2 mycelial growth kinetics and optimal fed-batch fermentation for beauvericin production.
Liu, YS; Wu, JY; Xu, LJ; Zhou, LG, 2011
)
2.03
"Beauvericin is a mycotoxin with antiviral, antibacterial, nematicidal, insecticidal, cytotoxic, and apoptotic activity. "( Beauvericin induced erythrocyte cell membrane scrambling.
Kucherenko, Y; Lang, F; Qadri, SM, 2011
)
3.25
"Beauvericin is a cyclic hexadepsipeptide mycotoxin, which has insecticidal, antimicrobial, antiviral and cytotoxic activities. "( Beauvericin, a bioactive compound produced by fungi: a short review.
Wang, Q; Xu, L, 2012
)
3.26
"Beauvericin (BEA) is a bioactive compound produced by the secondary metabolism of several Fusarium strains and is known to have various biological activities. "( Influence of different soluble dietary fibers on the bioaccessibility of the minor Fusarium mycotoxin beauvericin.
Font, G; Mañes, J; Meca, G; Meneghelli, G; Ritieni, A, 2012
)
2.04
"Beauvericin (BEA) is a bioactive compound produced by the secondary metabolism of several Fusarium strains and known to have various biological activities. "( Chemical reduction of the mycotoxin beauvericin using allyl isothiocyanate.
Luciano, FB; Mañes, J; Meca, G; Tsao, R; Zhou, T, 2012
)
2.1
"Beauvericin (BEA) is a cyclohexadepsipeptide mycotoxin which has insecticidal properties and produces cytotoxic effects in mammalian cells. "( Study of the cytotoxic activity of beauvericin and fusaproliferin and bioavailability in vitro on Caco-2 cells.
Font, G; Meca, G; Prosperini, A; Ruiz, MJ, 2012
)
2.1
"Beauvericin is a mycotoxin that infects a wide variety of cereal grains. "( Beauvericin activates Ca2+-activated Cl- currents and induces cell deaths in Xenopus oocytes via influx of extracellular Ca2+.
Chen, YW; Chou, CJ; Jeng, CJ; Jow, GM; Tang, CY, 2005
)
3.21
"Beauvericin (BEA) is a cyclic hexadepsipeptide produced by Beauveria bassiana, Paecilomyces fumosoroseus, Paecilomyces tenuipes, Polyporus sulphurous, and a variety of Fusarium species. "( [Beauvericin: chemical and biological aspects and occurrence].
Klarić, MS; Pepeljnjak, S, 2005
)
2.68
"Beauvericin is a cyclohexadepsipeptide mycotoxin which has insecticidal properties and which can induce apoptosis in mammalian cells. "( Beauvericin production by Fusarium species.
Castella, G; Chelkowski, J; Golinski, P; Kostecki, M; Logrieco, A; Moretti, A; Ritieni, A, 1998
)
3.19

Effects

ExcerptReferenceRelevance
"New beauvericins have been synthesized using the nonribosomal peptide synthetase BbBEAS from the entomopathogenic fungus Beauveria bassiana. "( In vitro chemoenzymatic and in vivo biocatalytic syntheses of new beauvericin analogues.
Denisiuk, A; Espinosa-Artiles, P; Feifel, SC; Matthes, D; Molnár, I; Müller, J; Richter, L; Süssmuth, RD; Xu, Y, 2012
)
1.17

Actions

ExcerptReferenceRelevance
"Beauvericin at a lower concentration (10(-6) M) competitively inhibited the Ca2+-induced contraction in depolarized muscle, whereas higher concentrations (3 x 10(-6) or 10(-5) M) non-competitively inhibited this contraction."( Inhibitory effect of beauvericin on a high K+-induced tonic contraction in guinea-pig taenia coli.
Kimura, M; Kitayama, T; Matsuoka, K; Nakajyo, S; Shimizu, K; Urakawa, N; Yamamura, Y, 1987
)
1.31

Toxicity

Beauvericin (BEA) and enniatins are toxic ionophoric cyclodepsipeptides that mainly occur in grains.

ExcerptReferenceRelevance
"The cyclic hexadepsipeptide beauvericin, initially known as a secondary metabolite produced by the entomopathogenic fungus Beauveria bassiana and toxic to Artemia salina larvae, has been more recently recognized as an important mycotoxin synthesized by a number of Fusarium strains, which parasite maize, wheat and rice."( Beauvericin cytotoxicity to the invertebrate cell line SF-9.
Caiaffa, MF; Calo', L; Fornelli, F; Macchia, L; Nenna, S; Tursi, A, 2003
)
2.06
" This study indicates that enniatins, fungal metabolites that are commonly found in grain in Northern Europe, may have an underestimated toxic potential."( Cytotoxicity of enniatins A, A1, B, B1, B2 and B3 from Fusarium avenaceum.
Eriksen, GS; Ivanova, L; Skjerve, E; Uhlig, S, 2006
)
0.33
" However, data from the brine shrimp bioassay showed that further toxic metabolites within this complex need to be characterized."( Further data on the production of beauvericin, enniatins and fusaproliferin and toxicity to Artemia salina by Fusarium species of Gibberella fujikuroi species complex.
Logrieco, A; Moretti, A; Mulè, G; Ritieni, A, 2007
)
0.62
"5) estimated by MTT reduction assay shows that BEA is three times more toxic than OTA."( Beauvericin and ochratoxin A genotoxicity evaluated using the alkaline comet assay: single and combined genotoxic action.
Darabos, D; Kasuba, V; Klarić, MS; Pepeljnjak, S; Rozgaj, R, 2010
)
1.8
" Once the potential interaction has been detected, a quantitative assessment is necessary to ensure and characterize these interactions, that is, each mycotoxin contributes to the toxic effect in accord with its own potency."( Cytotoxic effects of mycotoxin combinations in mammalian kidney cells.
Font, G; Juan-García, A; Macáková, P; Ruiz, MJ, 2011
)
0.37
" Our results indicate that the co-occurrence of low concentrations of mycotoxin in food may increase their toxic effects."( Cytotoxic effects induced by patulin, sterigmatocystin and beauvericin on CHO-K1 cells.
Abid-Essefi, S; Bacha, H; Berrada, H; Mallebrera, B; Ruiz, MJ; Zouaoui, N, 2016
)
0.68
" Unfortunately, we still know very little about the bioavailability and toxic potentials of many of these less characterized mycotoxins, including the large family of enniatins."( Enniatin B and beauvericin are common in Danish cereals and show high hepatotoxicity on a high-content imaging platform.
Have Rasmussen, P; Jensen, U; Lund Hansen, N; Svingen, T; Taxvig, C; Vinggaard, AM, 2017
)
0.81
"Emerging Fusarium mycotoxins include the toxic secondary metabolites fusaproliferin, enniatins, beauvericin (BEA), and moniliform."( Occurrence, toxicity, bioaccessibility and mitigation strategies of beauvericin, a minor Fusarium mycotoxin.
Luciano, FB; Luz, C; Mañes, J; Meca, G; Saladino, F, 2017
)
0.91
" OTA was the least toxic mycotoxin and DON and BEA showed similar acute toxicity."( Cytotoxicity against fish and mammalian cell lines and endocrine activity of the mycotoxins beauvericin, deoxynivalenol and ochratoxin-A.
Fernández-Cruz, ML; García-Herranz, V; Navas, JM; Valdehita, A, 2019
)
0.73
"Beauvericin (BEA) and enniatins are toxic ionophoric cyclodepsipeptides that mainly occur in grains."( Counteracting in Vitro Toxicity of the Ionophoric Mycotoxin Beauvericin-Synthetic Receptors to the Rescue.
De Saeger, S; Decleer, M; Madder, A; Ornelis, V; Rajkovic, A; Sas, B, 2019
)
2.2
" Cyclodepsipeptides are fungal molecules with potentially adverse and positive effects."( Comparative Structure-Activity Analysis of the Antimicrobial Activity, Cytotoxicity, and Mechanism of Action of the Fungal Cyclohexadepsipeptides Enniatins and Beauvericin.
Baydoun, E; Courvoisier-Dezord, E; Hijazi, A; Lafond, M; Maresca, M; Nicoletti, C; Olleik, H; Perrier, J; Xue, P, 2019
)
0.71

Pharmacokinetics

ExcerptReferenceRelevance
"o administration alone and co-administration with ketoconazole, which indicated a pharmacodynamic function may play a role in the synergistic effect on antifungal activity."( An inhibition study of beauvericin on human and rat cytochrome P450 enzymes and its pharmacokinetics in rats.
Dai, R; Mei, L; Zhang, L, 2009
)
0.66
" The purpose of this study was to evaluate the in vitro distribution and metabolism characteristics as well as the in vivo pharmacokinetic (PK) profile of BEA."( Study on In Vitro Metabolism and In Vivo Pharmacokinetics of Beauvericin.
Li, Y; Meng, G; Wu, C; Yuan, Y, 2022
)
0.96

Bioavailability

ExcerptReferenceRelevance
"The ATP-binding cassette transporter P-glycoprotein (P-gp) is known to limit both brain penetration and oral bioavailability of many chemotherapy drugs."( A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
Ambudkar, SV; Brimacombe, KR; Chen, L; Gottesman, MM; Guha, R; Hall, MD; Klumpp-Thomas, C; Lee, OW; Lee, TD; Lusvarghi, S; Robey, RW; Shen, M; Tebase, BG, 2019
)
0.51
" However, both mycotoxins potently interact with ABCB1 and ABCG2 transport functions suggesting influences on bioavailability of xenobiotics and pharmaceuticals."( Interactions between ABC-transport proteins and the secondary Fusarium metabolites enniatin and beauvericin.
Berger, W; Chiba, P; Dornetshuber, R; Heffeter, P; Koellensperger, G; Kopp, S; Lemmens-Gruber, R; Micksche, M; Schumacher, R; Sulyok, M, 2009
)
0.57
" The aim of this study was to determine the cytotoxicity of BEA and FUS in human epithelial colorectal adenocarcinoma HT-29 and Caco-2 cells, the transepithelial transport and the bioavailability using Caco-2 cells as a simulated in vitro gastrointestinal model of the human intestinal epithelium."( Study of the cytotoxic activity of beauvericin and fusaproliferin and bioavailability in vitro on Caco-2 cells.
Font, G; Meca, G; Prosperini, A; Ruiz, MJ, 2012
)
0.66
" Unfortunately, we still know very little about the bioavailability and toxic potentials of many of these less characterized mycotoxins, including the large family of enniatins."( Enniatin B and beauvericin are common in Danish cereals and show high hepatotoxicity on a high-content imaging platform.
Have Rasmussen, P; Jensen, U; Lund Hansen, N; Svingen, T; Taxvig, C; Vinggaard, AM, 2017
)
0.81
" Finally, the absolute bioavailability of BEA was evaluated by intravenous and oral administration in rats."( Study on In Vitro Metabolism and In Vivo Pharmacokinetics of Beauvericin.
Li, Y; Meng, G; Wu, C; Yuan, Y, 2022
)
0.96

Dosage Studied

ExcerptRelevanceReference
" Specifically, a microbial natural product library was screened for hits that synergize the effect of a low dosage of ketoconazole (KTC) that alone shows little detectable fungicidal activity."( High-throughput synergy screening identifies microbial metabolites as combination agents for the treatment of fungal infections.
An, R; Bian, J; Chen, X; Chen, Z; Dai, H; Fu, C; Gao, H; Goodfellow, M; Huang, R; Jiang, Y; Kuai, J; Liu, J; Liu, Z; Min, F; Pei, G; Song, Y; Sun, H; Sun, N; Wang, J; Yan, K; Yang, K; You, J; Yu, Z; Zhang, L; Zhang, S; Zhang, X; Zhang, Y; Zhao, W; Zheng, C; Zhou, G; Zhuo, Y, 2007
)
0.34
" For example, the accuracy and the precision of the method were determined by a recovery study at 80, 100 and 120% of the tablet dosage levels."( Development and Validation of Stability-Indicating Method for the Simultaneous Determination of Ketoconazole and Beauvericin in Pharmaceutical Tablets.
Liu, Y; Luan, Y; Tang, X; Tian, T; Yang, M; Zhao, Z; Zhu, M, 2016
)
0.65
" BEA showed a weak antagonistic effect at the androgen receptor and OTA produced a biphasic dose-response curve at the estrogen receptor."( Cytotoxicity against fish and mammalian cell lines and endocrine activity of the mycotoxins beauvericin, deoxynivalenol and ochratoxin-A.
Fernández-Cruz, ML; García-Herranz, V; Navas, JM; Valdehita, A, 2019
)
0.73
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (8)

RoleDescription
mycotoxinPoisonous substance produced by fungi.
antibiotic insecticidenull
apoptosis inhibitorAny substance that inhibits the process of apoptosis (programmed cell death) in multi-celled organisms.
fungal metaboliteAny eukaryotic metabolite produced during a metabolic reaction in fungi, the kingdom that includes microorganisms such as the yeasts and moulds.
ionophoreA compound which can carry specific ions through membranes of cells or organelles.
antifungal agentAn antimicrobial agent that destroys fungi by suppressing their ability to grow or reproduce.
P450 inhibitorAn enzyme inhibitor that interferes with the activity of cytochrome P450 involved in catalysis of organic substances.
antineoplastic agentA substance that inhibits or prevents the proliferation of neoplasms.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
cyclodepsipeptideA depsipeptide in which the amino and hydroxy carboxylic acid residues are connected in a ring.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (20)

Assay IDTitleYearJournalArticle
AID1875557Antiproliferative activity against human Huh-7 cells assessed as reduction in cell viability after 48 hr by CCK-8 assay2022Journal of natural products, 11-25, Volume: 85, Issue:11
Cytotoxic Cyclodepsipeptides and Cyclopentane Derivatives from a Plant-Associated Fungus
AID1666601Induction of DNA damage in human SU8686 cells assessed as increase gammaH2AX protein level at IC50 for 24 hrs in presence of 5 uM cisplatin by western blot analysis2020Bioorganic & medicinal chemistry, 02-15, Volume: 28, Issue:4
Targeting the DNA damage response (DDR) by natural compounds.
AID1270927Potentiation of antifungal activity of fluconazole against Candida albicans ATCC 24433 by checkerboard assay2015Journal of natural products, Nov-25, Volume: 78, Issue:11
Synergistic Antifungal Meroterpenes and Dioxolanone Derivatives from the Endophytic Fungus Guignardia sp.
AID1875559Antiproliferative activity against human HepG2 cells assessed as reduction in cell viability after 48 hr by CCK-8 assay2022Journal of natural products, 11-25, Volume: 85, Issue:11
Cytotoxic Cyclodepsipeptides and Cyclopentane Derivatives from a Plant-Associated Fungus
AID1666600Induction of DNA damage in human SU8686 cells assessed as tail DNA formation at IC50 by alkaline Comet assay2020Bioorganic & medicinal chemistry, 02-15, Volume: 28, Issue:4
Targeting the DNA damage response (DDR) by natural compounds.
AID1270909Antifungal activity against Candida albicans ATCC 24433 assessed as growth inhibition after 24 hrs by broth microdilution assay2015Journal of natural products, Nov-25, Volume: 78, Issue:11
Synergistic Antifungal Meroterpenes and Dioxolanone Derivatives from the Endophytic Fungus Guignardia sp.
AID1270917Antibiofilm activity against Candida albicans ATCC 24433 after 24 hrs in presence of fluconazole by XTT-based colorimetric assay2015Journal of natural products, Nov-25, Volume: 78, Issue:11
Synergistic Antifungal Meroterpenes and Dioxolanone Derivatives from the Endophytic Fungus Guignardia sp.
AID1270919Synergistic antibiofilm activity against Candida albicans ATCC 24433 assessed as fractional inhibition concentration index after 24 hrs in presence of fluconazole checkerboard assay2015Journal of natural products, Nov-25, Volume: 78, Issue:11
Synergistic Antifungal Meroterpenes and Dioxolanone Derivatives from the Endophytic Fungus Guignardia sp.
AID1875558Antiproliferative activity against rat MRMT-1 cells assessed as reduction in cell viability after 48 hr by CCK-8 assay2022Journal of natural products, 11-25, Volume: 85, Issue:11
Cytotoxic Cyclodepsipeptides and Cyclopentane Derivatives from a Plant-Associated Fungus
AID1270916Antibiofilm activity against Candida albicans ATCC 24433 after 24 hrs by XTT-based colorimetric assay2015Journal of natural products, Nov-25, Volume: 78, Issue:11
Synergistic Antifungal Meroterpenes and Dioxolanone Derivatives from the Endophytic Fungus Guignardia sp.
AID1666603Induction of DNA damage in human SU8686 cells assessed as increase in gammaH2AX nuclear foci under basal condition at IC50 by fluorometry method2020Bioorganic & medicinal chemistry, 02-15, Volume: 28, Issue:4
Targeting the DNA damage response (DDR) by natural compounds.
AID1270918Synergistic antibiofilm activity against Candida albicans ATCC 24433 assessed as fractional inhibition concentration ratio after 24 hrs in presence of fluconazole by checkerboard assay2015Journal of natural products, Nov-25, Volume: 78, Issue:11
Synergistic Antifungal Meroterpenes and Dioxolanone Derivatives from the Endophytic Fungus Guignardia sp.
AID1270913Antifungal activity against Candida albicans ATCC 24433 assessed as synergistic growth inhibition after 24 hrs in presence of fluconazole by broth microdilution assay2015Journal of natural products, Nov-25, Volume: 78, Issue:11
Synergistic Antifungal Meroterpenes and Dioxolanone Derivatives from the Endophytic Fungus Guignardia sp.
AID1270914Antifungal activity against Candida albicans ATCC 24433 assessed as fractional inhibition concentration ratio in presence of fluconazole by checkerboard assay2015Journal of natural products, Nov-25, Volume: 78, Issue:11
Synergistic Antifungal Meroterpenes and Dioxolanone Derivatives from the Endophytic Fungus Guignardia sp.
AID1270915Antifungal activity against Candida albicans ATCC 24433 assessed as fractional inhibition concentration index in presence of fluconazole by checkerboard assay2015Journal of natural products, Nov-25, Volume: 78, Issue:11
Synergistic Antifungal Meroterpenes and Dioxolanone Derivatives from the Endophytic Fungus Guignardia sp.
AID1296008Cytotoxic Profiling of Annotated Libraries Using Quantitative High-Throughput Screening2020SLAS discovery : advancing life sciences R & D, 01, Volume: 25, Issue:1
Cytotoxic Profiling of Annotated and Diverse Chemical Libraries Using Quantitative High-Throughput Screening.
AID1347160Primary screen NINDS Rhodamine qHTS for Zika virus inhibitors2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1347159Primary screen GU Rhodamine qHTS for Zika virus inhibitors: Unlinked NS2B-NS3 protease assay2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1346987P-glycoprotein substrates identified in KB-8-5-11 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1346986P-glycoprotein substrates identified in KB-3-1 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (266)

TimeframeStudies, This Drug (%)All Drugs %
pre-19908 (3.01)18.7374
1990's23 (8.65)18.2507
2000's61 (22.93)29.6817
2010's123 (46.24)24.3611
2020's51 (19.17)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 40.99

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index40.99 (24.57)
Research Supply Index5.59 (2.92)
Research Growth Index5.18 (4.65)
Search Engine Demand Index62.80 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (40.99)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Reviews12 (4.51%)6.00%
Case Studies0 (0.00%)4.05%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%
Other254 (95.49%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]